Discover the transformative impact of Anti-obesity medications (AOMs) like Ozempic, Wegovy, and Zepbound, alongside GLP-1 agonists, reshaping the obesity landscape. Gain insights into drug mechanisms, common side effects, and their influence on food behaviors. Explore the results of our consumer concept testing in the food and beverage industry. Join us to learn how the drugs work, side effects that occur frequently, and how changing behaviors will change food categories from snacking to QSR.

Contact

Danikka Semana